Company-wide revenue
Reported revenue in 2021 ¥1.5T Reported revenue in 2025 ¥2.47T
- growth amount
- +¥970.62B
- growth annualized
- +13.3%
- growth total
- +64.8%
Japanese company profile · 4578
Otsuka Holdings Co., Ltd.
In its FY2025 public filing, Otsuka Holdings Co., Ltd. reports Healthcare-related Business, Neutrapharma related business, Consumer-related businesses, Other Businesses. The page shows business-level revenue and profit where the source disclosures support comparison.
Original Japanese company name: 大塚ホールディングス株式会社
English company name from the issuer's official source. English company name source
Reported company-wide figures
What does this company do?
What does this company do?
Otsuka Holdings Co., Ltd.'s largest reported business by revenue in FY2025 was Healthcare-related Business.
The business with the highest reported segment profit in FY2025 was Healthcare-related Business.
FY2025 · fiscal year ended December 2025 View original filing ↗ The source document may be in Japanese.
Business structure
How does it make money?
| Business | Revenue from external customers | Revenue share | Segment profit (loss) |
|---|---|---|---|
| Healthcare-related Business | ¥1.74T ↗ | 70.6% | ¥445.3B ↗ |
| Neutrapharma related business | ¥577.62B ↗ | 23.4% | ¥57.72B ↗ |
| Other Businesses | ¥112.43B ↗ | 4.6% | ¥7.98B ↗ |
| Consumer-related businesses | ¥34.61B ↗ | 1.4% | ¥25.15B ↗ |
All values are in Japanese yen (JPY). No currency conversion is applied. FY2025 · fiscal year ended December 2025. Revenue and profit are shown only where the filing and data support a comparison.
Original Japanese label
- Healthcare-related Business
- 医療関連事業
- Neutrapharma related business
- ニュートラシューティカルズ関連事業
- Consumer-related businesses
- 消費者関連事業
- Other Businesses
- その他の事業
- Revenue from external customers
- 外部顧客売上
- Segment profit (loss)
- セグメント利益（損失）
Original Japanese label
- Healthcare-related Business
- 医療関連事業
- Neutrapharma related business
- ニュートラシューティカルズ関連事業
- Consumer-related businesses
- 消費者関連事業
- Other Businesses
- その他の事業
- Revenue from external customers
- 外部顧客売上
- Segment profit (loss)
- セグメント利益（損失）
Reported Revenue from external customers by business over time
Reported Revenue from external customers by business over time
| Fiscal year | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Healthcare-related Business | ¥977.51B | ¥1.14T | ¥1.36T | ¥1.63T | ¥1.74T |
| Neutrapharma related business | ¥376.6B | ¥437.01B | ¥483.32B | ¥557.01B | ¥577.62B |
| Consumer-related businesses | ¥31.89B | ¥35.85B | ¥37.07B | ¥33.75B | ¥34.61B |
| Other Businesses | ¥112.27B | ¥127.27B | ¥133.82B | ¥110.07B | ¥112.43B |
All amounts are in Japanese yen (JPY). Each figure links to the original Japanese filing. Blank cells indicate no comparable figure was disclosed. Business figures may not add up to consolidated figures.
What is growing?
What is growing?
Business revenue growth
Healthcare-related Business
Reported revenue in 2021 ¥977.51B Reported revenue in 2025 ¥1.74T
- growth amount
- +¥766.73B
- growth annualized
- +15.6%
- growth total
- +78.4%
View original filing
Neutrapharma related business
Reported revenue in 2021 ¥376.6B Reported revenue in 2025 ¥577.62B
- growth amount
- +¥201.02B
- growth annualized
- +11.3%
- growth total
- +53.4%
View original filing
Consumer-related businesses
Reported profit margin in 2022 +19.3%
Reported profit margin in 2025 +72.7%
- growth margin points
- +53.3
View original filing
Healthcare-related Business
Reported profit margin in 2022 +10.8%
Reported profit margin in 2025 +25.5%
- growth margin points
- +14.7
View original filing
This describes a reported period; it is not a forecast.
What has changed?
What has changed?
Not disclosed or not safely comparable in the available filings.
Source
Public filing
FY2025 · fiscal year ended December 2025
The source document may be in Japanese.
Filing ID: S100XUA7
View original filing ↗Ask about this company
Ask about this company
The source document may be in Japanese.